Devices, agents, and associated methods for selective modulation of renal nerves
US12226142B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 30, 2021 |
| Grant date | Feb 18, 2025 |
| Priority date | — |
| Expiry date | Sep 11, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2025/1052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Devices, agents, and associated methods for selective modulation of renal nerves by localized delivery of neural ablative substances are disclosed herein. One aspect of the present technology is directed to a method for delivering a neuromodulatory agent (e.g., capsaicin) via a catheter to a kidney of the patient. The neuromodulatory agent selectively neuromodulates afferent renal nerves in a patient compared efferent renal nerves of the patient. The method can also include removing the catheter from the patient after delivering the neuromodulatory agent to conclude the procedure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.